As climate change brings longer droughts, more frequent heat waves and increasingly unpredictable growing conditions to ...
Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...
Biotech is having a moment, and the numbers are hard to ignore. The SPDR S&P Biotech ETF (NYSEARCA:XBI) climbed 17.27% over ...
China and Hong Kong stocks rose on Monday as signs emerged that investor enthusiasm for artificial intelligence was ...
Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...
Healthcare veteran Dr Douglas Williams discusses the impact of recent political upheaval in the US and the prospect of major ...
Regencell Bioscience Holdings Limited (RGC) focuses on TCM-based treatments for ADHD and Autism, targeting significant ...
Investor's Business Daily on MSN
Why this biotech, up 14% since its breakout, is on the rise once again
Pharvaris stock jumped early Monday after the FDA agreed to review the company's experimental treatment for a serious ...
A biotech startup and an aerospace startup said their moves to Colorado were based on lifestyle issues and the state’s ...
It might pull it off, provided several things fall right in place.
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
SpudCell is not alive and cannot function independently, but researchers say it could become a building block for new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results